258 related articles for article (PubMed ID: 12702051)
1. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
3. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
4. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.
Camoglio L; te Velde AA; de Boer A; ten Kate FJ; Kopf M; van Deventer SJ
Eur J Immunol; 2000 May; 30(5):1486-95. PubMed ID: 10820397
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.
Dohi T; Fujihashi K; Kiyono H; Elson CO; McGhee JR
Gastroenterology; 2000 Sep; 119(3):724-33. PubMed ID: 10982767
[TBL] [Abstract][Full Text] [Related]
7. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.
Dohi T; Fujihashi K; Rennert PD; Iwatani K; Kiyono H; McGhee JR
J Exp Med; 1999 Apr; 189(8):1169-80. PubMed ID: 10209035
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses.
Mountford AP; Coulson PS; Cheever AW; Sher A; Wilson RA; Wynn TA
Immunology; 1999 Aug; 97(4):588-94. PubMed ID: 10457211
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice.
Ruyssers NE; De Winter BY; De Man JG; Loukas A; Pearson MS; Weinstock JV; Van den Bossche RM; Martinet W; Pelckmans PA; Moreels TG
Inflamm Bowel Dis; 2009 Apr; 15(4):491-500. PubMed ID: 19023900
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
[TBL] [Abstract][Full Text] [Related]
13. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.
Fuss IJ; Marth T; Neurath MF; Pearlstein GR; Jain A; Strober W
Gastroenterology; 1999 Nov; 117(5):1078-88. PubMed ID: 10535870
[TBL] [Abstract][Full Text] [Related]
15. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
[TBL] [Abstract][Full Text] [Related]
16. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
17. Regulatory role of the pituitary-adrenal axis in experimental colitis: effect of adrenalectomy on the clinical course and the TH1/TH2 immune profile.
Shibolet O; Alper R; Ilan Y; Weidenfeld J
Inflamm Bowel Dis; 2005 Dec; 11(12):1053-9. PubMed ID: 16306767
[TBL] [Abstract][Full Text] [Related]
18. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
